Results 171 to 180 of about 13,546 (186)

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2013
Su-Hyun Kim, Sun Ju Lee, Aeran Joung
exaly  

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset

Multiple Sclerosis Journal, 2014
Nicolas Collongues, R Marignier, Aksel Siva   +2 more
exaly  

Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2017
De-Cai Tian, Chun-Sheng Yang, Fu-Dong Shi   +2 more
exaly  

Neuromyelitis optica, psychiatric symptoms and primary polydipsia: a case report

General Hospital Psychiatry, 2010
Josh Woolley, Vanja C Douglas, Bruce A C Cree   +2 more
exaly  

The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates

Multiple Sclerosis Journal, 2017
Liene Elsone, Kerry Mutch, Tom Solomon   +2 more
exaly  

Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders

Multiple Sclerosis Journal, 2017
Su-Hyun Kim, Jae-Won Hyun, Aeran Joung   +2 more
exaly  

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica

Therapeutic Advances in Neurological Disorders, 2016
Nicolas Collongues, Jérôme De Sèze
exaly  

NEUROMYELITIS OPTICA

The Journal of Nervous and Mental Disease, 1939
openaire   +1 more source

Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints

Multiple Sclerosis Journal, 2016
Boram Park, Su-Hyun Kim, Jae-Won Hyun
exaly  

Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2014
So-Young Huh, Su-Hyun Kim, Jae-Won Hyun   +2 more
exaly